Xiyuan Zhang

机构：Rutgers, The State University of New Jersey, Qingdao University, The University of Melbourne, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Florey Institute of Neuroscience and Mental Health, Johnson University, Shanghai Mental Health Center, National Cancer Center, Qingdao Municipal Hospital, National Cancer Institute, Center for Cancer Research · ORCID：0000-0001-9949-5258

发表论文 230 篇 · 总被引 1756 次 · h-index 25

代表论文

• Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas (2025 · Life Science Alliance · 被引 2)
• Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer (2026 · Cancers · 被引 1)
• Bioinspired aligned electroconductive hydrogel nanofiber patch enhances peripheral nerve repair through mechanosensitive calcium influx and focal adhesion kinase/protein kinase B pathway activation (2026 · Acta Biomaterialia · 被引 1)
• Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts (2025 · Molecular Therapy Oncology · 被引 1)
• ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma (2026 · Journal for ImmunoTherapy of Cancer)